Oncology

SOHO is the premier meeting that focuses specifically on new advances and practical clinical applications in the field of hematologic malignancies. The speakers are a multidisciplinary group of internationally recognized experts that represent the spectrum of these diseases.

The SOHO 2025 meeting theme will be “Unleashing AI, Genomics, Targets, and Immune Engineering” as it relates to the field of hematologic oncology. Topics will be covered in the latest advances in the pathophysiology and therapy of: leukemias, lymphomas, myeloma, myelodysplastic neoplasms, myeloproliferative neoplasms, related malignancies and exciting developments in cellular therapy. 

More than 1,200 pediatric hematology/oncology professionals from around the world attend the ASPHO Conference each year. The leading meeting for the field, the ASPHO Conference allows attendees to receive high-quality educational content, network with their colleagues, and discover innovative advancements in pediatric hematology/oncology.

The AACR Annual Meeting is the critical driver of progress against cancer, the place where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share and discuss the latest breakthroughs. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting showcases cutting-edge cancer science and medicine.

The West Virginia Oncology Society (WVOS) is a powerful community of oncologists, nurse practitioners, physician assistants, and other allied health professionals who provide a voice for multidisciplinary cancer care teams and the patients they serve.

Founded in 2008, WVOS is the largest oncology professional organization in the state. Members rely on us to provide innovative resources to help them stay ahead of the shifting healthcare landscape and challenges that directly impact the high-quality care their patients deserve—both locally and on a national level.

Society of Utah Medical Oncologists

Managing lung cancer has become increasingly complicated – reflecting the transformative benefits we see with immunotherapy and targeted therapy. Learn the best way to deliver these drugs from the very investigators leading the research. This two-day CME-event will review the latest advances in lung cancer focused on what a medical oncologist needs to know to provide state-of-the-art care today. Featured speaker and TxSCO President Debra Patt, MD, PhD, MBA, FASCO, will share the latest on healthcare policy, while expert faculty will cover the basics (”What is NGS?”) and the advanced (“How can we predict and prevent acquired resistance?”) making this conference appropriate for all levels of training and experience.

Maryland/District of Columbia Society of Clinical Oncology. This program is designed for physicians and allied professionals, though industry may attend within the limitation of their corporate packages (see below). Only the key corporate contacts may register industry attendees. 

Medical research and the convergence of healthcare and technology continue to grow at an unprecedented rate requiring today’s leaders to think beyond traditional practices to improve the quality of cancer care delivery. Attend the TOPS Annual Conference to explore the regulatory hurdles facing some of today’s most cutting-edge advances, get the keys to unlocking successful implementation of value-based care, and learn what federal and state-level policy priorities you should be watching.

Dramatic changes in healthcare reform are requiring oncology practices to think outside the box in order to maximize operations and contain costs. Join us for the annual North Carolina Oncology Association Joint Conference/ South Carolina Oncology Society to experience collaborative opportunities that will strengthen patient care across the Carolinas, and walk away with effective strategies to meet your everyday challenges. Engaging speakers, insider perspectives, and a bevy of local experts offer reflection on national policy and state-level dynamics, and innovative ideas in this unfamiliar landscape.